Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-12-21
2000-09-05
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548496, A61K 31404, C07D20920, A01N 900, A01N 2516, A01N 2528
Patent
active
061143731
ABSTRACT:
The invention involves a novel chemical compound, N-acetyl-5,6-dimethoxytryptamine (compound I), which can also be defined as a melatonin derivative. The molecular weight of compound I is 262 and the chemical structure is as follows. ##STR1## Compound I possesses potent in vitro and in vivo free radical scavenging capacity and exhibits protective effects against convulsions and brain damage induced by oxidative stress. It holds potential clinical usage for preventing and treating diseases which involve free radicals and oxidative stress.
REFERENCES:
patent: 5210215 (1993-05-01), Politi et al.
patent: 5283343 (1994-02-01), Dubocovich et al.
patent: 5403851 (1995-04-01), D'Orlando
patent: 5756507 (1998-05-01), Goulet et al.
CA 129: 302483 Melatonin Receptor Ligands: Synthesis . . . Study, Mor et al, 1998.
CA 127: 12976 1-(2-Alkanamidoethyl)-6-methoxyindole Derivatives: A . . . Analogs, Tarzia et al, 1997.
Reiter Russel Joseph
Tan Dun-Xian
Yan Mei-ting
LandOfFree
N-acetyl-5,6-dimethoxytryptamine and its free radical scavenging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-acetyl-5,6-dimethoxytryptamine and its free radical scavenging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-acetyl-5,6-dimethoxytryptamine and its free radical scavenging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2212575